Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL4163600 | 0.93 | LPAR3 (0.49) | LPAR3 | |
| SCHEMBL3804996 | 0.89 | FAAH (0.42) | FAAHALDH1A1CNR1CNR2 | |
| SCHEMBL4602462 | 0.89 | FAAH (0.42) | FAAHALDH1A1CNR1CNR2 | |
| SCHEMBL7139631 | 0.89 | FAAH (0.42) | FAAHALDH1A1CNR1CNR2 | |
| SCHEMBL5538149 | 0.89 | FAAH (0.42) | FAAHALDH1A1CNR1CNR2 | |
| SCHEMBL1142548 | 0.88 | ALDH1A1 (0.47) | FAAHTRPV1ALDH1A1CNR1CNR2 | |
| SCHEMBL1142899 | 0.88 | FAAH (0.44) | FAAHTRPV1ALDH1A1CNR1CNR2 | |
| SCHEMBL1142291 | 0.88 | FAAH (0.44) | FAAHTRPV1ALDH1A1CNR1CNR2 | |
| SCHEMBL1142329 | 0.88 | ALDH1A1 (0.47) | FAAHTRPV1ALDH1A1CNR1CNR2 | |
| SCHEMBL4018632 | 0.88 | ALDH1A1 (0.51) | FAAHTRPV1ALDH1A1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3073263-B1 | DEVICE, COMPOSITION AND METHOD FOR TISSUE-BASED DIAGNOSIS | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | claimed |
| CN-104655828-B | System, the method and apparatus of diagnosis based on tissue | 加州大学评议会 | 2018-04-27 | — | — | CN | claimed |
| US-9848853-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-26 | — | — | US | claimed |
| EP-3073263-A1 | SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS | The Regents of the University of California (US) | 2016-09-28 | — | — | EP | claimed |
| US-20160235392-A1 | SYSTEM, METHOD AND DEVICES FOR TISSUE-BASED DIAGNOSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-08-18 | — | — | US | claimed |
| US-9328324-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-05-03 | — | — | US | claimed |
| US-20150344834-A1 | System, Method and Devices for Tissue-Based Diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-12-03 | — | — | US | claimed |
| CN-104655828-A | SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS | UNIV CALIFORNIA | 2015-05-27 | — | — | CN | claimed |
| US-8945482-B2 | System, method and device for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-02-03 | — | — | US | claimed |
| EP-1163902-B1 | Transdermal preparation containing hydrophilic or salt-form drug | PACIFIC CORP (KR) | 2007-01-17 | — | — | EP | claimed |
| EP-0948362-B1 | ESSENTIAL OIL SOLID COMPOSITIONS | MONOPACE PTY LTD (AU) | 2006-02-01 | — | — | EP | claimed |
| EP-1100465-B1 | MEDICINAL AEROSOL FORMULATIONS | JAGO RES AG (CH) | 2004-11-24 | — | — | EP | claimed |
| US-11607407-B2 | Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use | RELMADA THERAPEUTICS, INC. (US) | 2023-03-21 | — | — | US | disclosed |
| CN-107115326-B | Skin pharmaceutical composition of 1-methyl-N- (2, 6-xylyl) -2-piperidine formamide and using method thereof | 雷尔玛达治疗股份有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-2557924-B1 | DERMAL PHARMACEUTICAL COMPOSITIONS OF 1-METHYL-2',6'-PIPECOLOXYLIDIDE AND METHOD OF USE | RELMADA THERAPEUTICS INC (US) | 2019-06-12 | — | — | EP | disclosed |
| US-9848853-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-26 | — | — | US | disclosed |
| US-20040077501-A1 | Agrochemical formulation aid composition and uses thereof | ADJUVANTS PLUS INC. (CA) | 2004-04-22 | — | — | US | disclosed |
| EP-1330159-A1 | AGROCHEMICAL FORMULATION AID COMPOSITION AND USES THEREOF | Adjuvants Plus Inc. (CA) | 2003-07-30 | — | — | EP | disclosed |
| WO-2002034047-A1 | AGROCHEMICAL FORMULATION AID COMPOSITION AND USES THEREOF | ADJUVANTS PLUS INC. (CA) | 2002-05-02 | — | — | WO | disclosed |
| US-5171475-A | Progenitor solution of solvent, emulsifier, surfactant having specific polarity and refractive index; water | PENETONE CORPORATION (US) | 1992-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11607407-B2 | Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use | PIP4K2C, PIP5K1C, PIP4K2A | FAAH 4077/4885TRPV1 1716/4885ALDH1A1 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.